FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention

[FDA]

Today, the FDA approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV.


Baca selengkapnya di : http://www.fda.gov...